Product Images Lisinopril
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Lisinopril NDC 43353-270 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Lisinopril is a medication provided in tablet form with a strength of 40mg and 30 tablets per container. The drug is manufactured by Ivax Pharmaceuticals Inc, Hauppauge, NY and repackaged by Aphena Pharma in Cookaville, TN 38508. The specific batch number is SW10802, with an expiry date of 27th February 2018 and Lot number 12348. It should be stored between 20-25 degrees Celsius and dispensed with caution with respect to USP controlled foom temperalset. This medicine should be kept away from children.*
This is a description for a medication called Lisinopril, with a strength of 25mg. The medication comes in a bottle with 90 tablets. Unfortunately, due to the limited and unclear text, it is difficult to provide an accurate description of the medication.*
This is a medication, Lisinopril, which is available in 20mg strength and comes in a pack of 30 tablets. No further information is available in the given text.*
This is a prescription drug named Lisinopril, which is available as 5mg tablets in a pack containing 30 tablets. There could be some issue with the format or quality of the text as there are some random characters and symbols mixed in the text.*
This is a medication information that describes a pack of 30 tablets of Lisinopril, which is a drug used to treat high blood pressure and heart failure.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.